Seaport Therapeutics, Inc. (SPTX) Form 10-K Annual Reports
Seaport Therapeutics, Inc. (SPTX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: SPTX
CIK: 2042347
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerThomas Feeley
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0001193125-26-352401 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-05 | — | SCHEDULE 13G Filing | 0001193125-26-333914 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-05 | — | SCHEDULE 13G Filing | 0001193125-26-333719 | View SEC Doc Filr Page |
| 10-Q | 2026-08-03 | 2026-06-30 | 10-Q | 0001193125-26-329537 | View SEC Doc Filr Page |
| 8-K | 2026-08-03 | 2026-08-03 | 8-K | 0001193125-26-329528 | View SEC Doc Filr Page |
| 4 | 2026-06-24 | 2026-06-22 | 4 | 0001193125-26-280175 | View SEC Doc Filr Page |
| 10-Q | 2026-06-08 | 2026-03-31 | 10-Q | 0001193125-26-260678 | View SEC Doc Filr Page |
| 8-K | 2026-06-08 | 2026-06-08 | 8-K | 0001193125-26-260671 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-05-11 | — | SCHEDULE 13D Filing | 0000950142-26-001350 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-11 | — | SCHEDULE 13G Filing | 0000886982-26-000211 | View SEC Doc Filr Page |
| 3 | 2026-05-06 | 2026-05-04 | OWNERSHIP DOCUMENT | 0000950142-26-001309 | View SEC Doc Filr Page |
| 3 | 2026-05-06 | 2026-05-04 | OWNERSHIP DOCUMENT | 0000950142-26-001308 | View SEC Doc Filr Page |
| 4 | 2026-05-06 | 2026-05-04 | 4 | 0001193125-26-209701 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-05-06 | — | SCHEDULE 13D Filing | 0001193125-26-209100 | View SEC Doc Filr Page |
| 4 | 2026-05-04 | 2026-04-30 | 4 | 0001193125-26-204507 | View SEC Doc Filr Page |
| 4 | 2026-05-04 | 2026-05-04 | 4 | 0001193125-26-204494 | View SEC Doc Filr Page |
| 4 | 2026-05-04 | 2026-04-30 | 4 | 0001193125-26-204493 | View SEC Doc Filr Page |
| 4 | 2026-05-04 | 2026-04-30 | 4 | 0001193125-26-204484 | View SEC Doc Filr Page |
| 4 | 2026-05-04 | 2026-04-30 | 4 | 0001193125-26-204483 | View SEC Doc Filr Page |
| 4 | 2026-05-04 | 2026-04-30 | 4 | 0001193125-26-204479 | View SEC Doc Filr Page |
| 4 | 2026-05-04 | 2026-04-30 | 4 | 0001193125-26-204471 | View SEC Doc Filr Page |
| 4 | 2026-05-04 | 2026-04-30 | 4 | 0001193125-26-204468 | View SEC Doc Filr Page |
| 4 | 2026-05-04 | 2026-04-30 | 4 | 0001193125-26-204465 | View SEC Doc Filr Page |
| 4 | 2026-05-04 | 2026-05-04 | 4 | 0001193125-26-204458 | View SEC Doc Filr Page |
| 4 | 2026-05-04 | 2026-04-30 | 4 | 0001193125-26-204456 | View SEC Doc Filr Page |